Scheen A, Cession-Fossion A, Scheen-Lavigne M, Luyckx A
Horm Metab Res. 1982 May;14(5):240-5. doi: 10.1055/s-2007-1018982.
The present study aimed at investigating the effects of an epinephrine (EPI) intravenous infusion (10 micrograms/min for 30 min) in normal subjects and in obese patients before and after 13 days of protein-supplemented fasting (PSF, 70 g protein/day). Blood glucose, plasma free fatty acids (FFA), lactate, insulin (IRI) and glucagon were determined before, during (15, 30 min) and after (+30 and +60 min) the EPI infusion. 1. When compared to lean control subjects, obese patients exhibited a less marked rise in blood glucose and a more important increase in plasma FFA, EPI infusion decreased IRI plasma levels in normals but not in the obese. Plasma glucagon was lower in the obese under basal conditions and their A cell reactivity to EPI was clearly reduced. 2. Comparison of the results obtained in obese patients before and after PSF revealed that EPI-induced blood glucose rise was not altered despite lower basal values after PSF. Plasma lactate response was impaired, probably because of the depletion in muscle glycogen. Reduction in basal plasma IRI was associated with a significantly higher FFA mobilization. Abnormally low basal EPI-stimulated glucagon concentrations persisted after PSF despite concomitant reductions in blood glucose and plasma IRI.
本研究旨在调查肾上腺素(EPI)静脉输注(10微克/分钟,持续30分钟)对正常受试者以及蛋白质补充禁食(PSF,70克蛋白质/天)13天前后肥胖患者的影响。在EPI输注前、输注期间(15、30分钟)和输注后(+30和+60分钟)测定血糖、血浆游离脂肪酸(FFA)、乳酸、胰岛素(IRI)和胰高血糖素。1. 与瘦的对照受试者相比,肥胖患者血糖升高不明显,血浆FFA升高更显著,EPI输注降低了正常受试者的血浆IRI水平,但对肥胖患者无此作用。肥胖患者基础状态下血浆胰高血糖素较低,其A细胞对EPI的反应明显降低。2. 对肥胖患者PSF前后的结果进行比较发现,尽管PSF后基础值较低,但EPI诱导的血糖升高未改变。血浆乳酸反应受损,可能是由于肌肉糖原耗竭。基础血浆IRI降低与FFA动员显著增加有关。尽管血糖和血浆IRI同时降低,但PSF后基础EPI刺激的胰高血糖素浓度仍异常低。